Miocardiopatía restrictiva, arritmogénica y de estrés y otras miocardiopatías

  1. García Campos, A. 1
  2. Pérez Domínguez, M. 1
  3. Díaz Fernández, B. 1
  4. González Juanetey, J.R. 1
  1. 1 Servicio de Cardiología. Hospital Clínico Universitario de Santiago de Compostela. Santiago de Compostela. La Coruña. España. CIBERCV
Zeitschrift:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Datum der Publikation: 2021

Titel der Ausgabe: Enfermedades cardiovasculares (VIII)

Serie: 13

Nummer: 42

Seiten: 2459-2475

Art: Artikel

DOI: 10.1016/J.MED.2021.09.022 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Medicine: Programa de Formación Médica Continuada Acreditado

Ziele für nachhaltige Entwicklung

Zusammenfassung

Restrictive, arrhythmogenic, and stress cardiomyopathies and other cardiomyopathies Restrictive, arrhythmogenic, and stress cardiomyopathies are less frequent entities than hypertrophic or dilated cardiomyopathy, but they can have a significant impact on a patient's management and prognosis. Deep knowledge of these cardiomyopathies is fundamental for guiding the process that leads to a correct diagnosis. In this work, we will study the most relevant aspects of these cardiomyopathies.

Bibliographische Referenzen

  • Arbustini E, Favalli V, Narula N, Serio A, Grasso M. Left ventricular noncompaction: A distinct genetic cardiomyopathy? J Am Coll Cardiol. 2016;68(9):949-66.
  • Beffagna G, Zorzi A, Pilichou K, Perazzolo Marra M, Rigato I, Corrado D. Arrhythmogenic Cardiomyopathy. Eur Heart J. 2020;41(47):4457-62.
  • Bossone E, Lyon A, Citro R, Athanasiadis A, Meimoun P, Parodi G. Takotsubo cardiomyopathy: An integrated multi imaging approach. Eur Heart J Cardiovasc Imaging. 2014;15(4):366-7.
  • Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141(11):858-65.
  • Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG. Clinical characteristics and Thrombolysis in Myocardial Infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004;94(3):343-6.
  • Corrado D, Van Tintelen PJ, McKenna WJ, Hauer RNW, Anastastakis A, Asimaki A. Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J. 2020;41(14):1414-27b.
  • Corrado D, Link MS, Calkins H. Arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2017;376(1):61-72.
  • Corrado D, Wichter T, Link MS, Hauer RN, Marchlinski FE, Anastasakis A. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement. Circulation. 2015;132(5):441-53.
  • Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, Lazzari M. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020;319:106-14.
  • Dorbala S, Cuddy S, Falk RH. How to image cardiac amyloidosis: A practical approach. JACC Cardiovasc Imaging. 2020;13(6):1368-83.
  • Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P. Classification of the cardiomyopathies: A position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270-6.
  • Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. Eur J Heart Fail. 2019;21(8):955-64.
  • Gati S, Papadakis M, Papamichael ND, Zaidi A, Sheikh N, Reed M. Reversible de novo left ventricular trabeculations in pregnant women: Implications for the diagnosis of left ventricular noncompaction in low risk populations. Circulation. 2014;130(6):475-83.
  • Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39(22):2032-46.
  • Ghadri JR, Cammann VL, Jurisic S, Seifert B, Napp LC, Diekmann J. A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail. 2017;19(8):1036-42.
  • Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, outcome, and management. Eur Heart J. 2018;39(22):2047-62.
  • Giustino G, Croft LB, Oates CP, Rahman K, Lerakis S, Reddy VY. Takotsubo Cardiomyopathy in COVID-19. J Am Coll Cardiol. 2020; 76(5):628-9.
  • González-López E, Gallego-Delgado M, Guzzo-Merello G, de Haro del Moral FJ, Cobo-Marcos M, Robles C. Wild type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36(38):2585-94.
  • González-López E, López-Sainz Á, García-Pavia P. Diagnóstico y tratamiento de la amiloidosis cardiaca por transtiretina. Progreso y esperanza. Rev Española Cardiol. 2017;70(11):991-1004.
  • Hänselmann A, Veltmann C, Bauersachs J, Berliner D. Dilated cardiomyopathies and non-compaction cardiomyopathy. Herz. 2020;45(3): 212-20.
  • Haugaa KH, Basso C, Badano LP, Bucciarelli-Ducci C, Cardim N, Gaemperli O. Comprehensive multimodality imaging approach in arrhythmogenic cardiomyopathy : an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2017;18(3):237-53.
  • Hoorntje ET, Te Rijdt WP, James CA, Pilichou K, Basso C, Judge DP. Arrhythmogenic cardiomyopathy: Pathology, genetics, and concepts in pathogenesis. Cardiovasc Res. 2017;113(12):1521-31.
  • Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86(6):666-71.
  • Kato K, Lyon AR, Ghadri JR, Templin C. Takotsubo syndrome: Aetiology, presentation and treatment. Heart. 2017;103(18):1461-9.
  • Kayvanpour E, Sedaghat-Hamedani F, Gi WT, Tugrul OF, Amr A, Haas J. Clinical and genetic insights into non compaction: a meta-analysis and systematic review on 7598 individuals. Clin Res Cardiol. 2019; 108(11):1297-308.
  • Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR. Current state of knowledge on Takotsubo syndrome: A position statement from the Taskforce on Takotsubo syn-drome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8-27.
  • Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur Heart J. 2010;31(7):806-14.
  • Martínez-Naharro A, Baksi AJ, Hawkins PN, Fontana M. Diagnostic imaging of cardiac amyloidosis. Nat Rev Cardiol. 2020;17(7):413-26.
  • Martínez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Northfield Il). 2018;18(2):30-5.
  • McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J. 1994;71(3):215-8.
  • Medina de Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D. Stress cardiomyopathy diagnosis and treatment: JACC State of the Art Review. J Am Coll Cardiol. 2018;72(16):1955-71.
  • Militaru S, Ginghina C, Popescu BA, Saftoiu A, Linhart A, Jurcut R. Multimodality imaging in Fabry cardiomyopathy: From early diagnosis to therapeutic targets. Eur Heart J Cardiovasc Imaging. 2018;19(12):1313-22.
  • Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008; 10(1):1-8.
  • Muchtar E, Blauwet LA, Gertz MA. Restrictive cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):819-37.
  • Pelliccia F, Kaski JC, Crea F, Camici PG. Pathophysiology of Takotsubo Syndrome. Circulation. 2017;135(24):2426-41.
  • Pelliccia F, Kaski JC, Camici PG. Takotsubo syndrome’s pathophysiology: Still a mystery? Eur Heart J. 2019;40(24):1989.
  • Pereira NL, Grogan M, Dec GW. Spectrum of restrictive and infiltrative cardiomyopathies: Part 1 of a 2 Part Series. J Am Coll Cardiol. 2018; 71(10):1130-48.
  • Pereira NL, Grogan M, Dec GW. Spectrum of restrictive and infiltrative cardiomyopathies: Part 2 of a 2 Part Series. J Am Coll Cardiol. 2018;71(10): 1149-66.
  • Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH. Left ventricular non-compaction: Insights from car-diovascular magnetic resonance imaging. J Am Coll Cardiol. 2005; 46(1):101-5.
  • Pieske B, Tschöpe C, De Boer RA, Fraser AG, Anker SD, Donal E. How to diagnose heart failure with preserved ejection fraction: The HFA-PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297-317.
  • Plácido R, Cunha Lopes B, Almeida AG, Rochitte CE. The role of cardiovascular magnetic resonance in takotsubo syndrome. J Cardiovasc Magn Reson. 2016;18(1):68.
  • Putko BN, Wen K, Thompson RB, Mullen J, Shanks M, Yogasundaram H. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment. Heart Fail Rev. 2015;20(2):179-91.
  • Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O. Systemic cardiac amyloidoses: Disease profiles and clinical courses of the 3 main types. Circulation. 2009;120(13):1203-12.
  • Redfors B, Vedad R, Angerås O, Råmunddal T, Petursson P, Haraldsson I. Mortality in takotsubo syndrome is similar to mortality in myocardial infarction : A report from the SWEDEHEART. Int J Cardiol. 2015;185:282-9.
  • Ross SB, Jones K, Blanch B, Puranik R, McGeechan K, Barratt A. A systematic review and meta-analysis of the prevalence of left ventricular non compaction in adults. Eur Heart J. 2020;41(14):1428-36b.
  • Schutte DP, Essop MR. Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation. 2001;103(14):2490-7.
  • Stiermaier T, Moeller C, Oehler K, Desch S, Graf T, Eitel C. Long term excess mortality in takotsubo cardiomyopathy: predictors, causes and clinical consequences. Eur J Heart Fail. 2016;18(6):650-6.
  • Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373(10):929-38.
  • Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Da-rrieux FCC. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Hear Rhythm. 2019;16(11):e301-e372.
  • Towbin JA, Lorts A, Jefferies JL. Left ventricular non compaction cardiomyopathy. Lancet. 2015;386(9995):813-25.
Fuente de los datos: Dialnet